Sanguina, an Atlanta- based health Technology developer, wants to make fingernail selfies a digital biomarker for iron deficiency
Sanguina, an Atlanta- based health technology developer, wants to make fingernail selfies a digital biomarker for iron deficiency by launching an app in the Google Play Store which will help in the early detection of iron deficiency disease Anemia.
An Atlanta-based health technology developer, Sanguina is launching a mobile app in the Google Play Store to detect the deficiency of iron in the body by using pictures of the fingernails.
This app works by measuring the levels of haemoglobin in the human which is a major factor for the cause of Anemia. It can be done by examination and analyzing of the person’s nail.
Anemia is a serious public health problem that affects more than 1.62 million people all around the world including women, children, athletes, and the elderly. WHO estimated that about 42% of children less than 5 years of age and 40% of pregnant women worldwide are anemic.
Anemia can cause yellowing of eyes, paleness of skin, shortening of breath, muscular weakness, rapid heart rate, pregnancy complications, and even heart ailments like cardiac arrest in severe conditions as said by the company. They also added that this AnemoCheck is the first smartphone application to measure the haemoglobin levels. This app can help to determine anemia at an early stage and this app can be used not only for the determination of anemia but also to provide information to cure the condition.
Sanguina, health technology developer is based on an algorithm that measures the level of haemoglobin in the blood by analyzing and examination of people’s nail color.
This non-invasive anemia detection tool is the only type of app-based system that has the potential to replace a common blood test quoted by Dr Lam, a clinical haematologist bioengineer at the Aflac Cancer and Blood Disorders Centre of Children’s Healthcare of Atlanta, associate professor of paediatrics at Emory University School of Medicine, and a faculty member in the Wallace H. Coulter Department of Biomedical Engineering at Emory University and Georgia Tech.
According to a statement, The Seed Lab, XRC Labs, as well as grants from The National Science Foundation and the National Institutes of Health have funded over $4.2 million in Sanguina.